Inventor · disambiguated record
Rajagopal Bakthavatchalam
Also filed as: BAKTHAVATCHALAM RAJAGOPAL
38 granted patents·20 pending applications·944 citations·filing 1997–2018
98Inventor score
Files withNEUROGEN CORP23BRISTOL MYERS SQUIBB PHARMA CO8BAKTHAVATCHALAM RAJAGOPAL6DU PONT PHARM CO6JANSSEN PHARMACEUTICA NV3
Top patents by PatentIndex Score
58 records- 0197US6107301A1N-alkyl-N-arylpyrimidinamines and derivatives thereofDU PONT PHARM CO·Filed 1997·Granted Aug 22, 2000·192 cites·9 claims
- 0296US6566367B2Spiro[isobenzofuran-1,4′-piperidin]-3-ones and 3H-spiroisobenzofuran-1,4′-piperidinesPFIZER·Filed 2001·Granted May 20, 2003·124 cites·23 claims
- 0395US6723730B2Capsaicin receptor ligandsNEUROGEN CORP·Filed 2001·Granted Apr 20, 2004·105 cites·185 claims
- 0494US9453002B2Substituted imidazoles as N-type calcium channel blockersJANSSEN PHARMACEUTICA NV·Filed 2013·Granted Sep 27, 2016·18 cites·24 claims
- 0593US7074799B2Substituted quinazolin-4-ylamine analoguesNEUROGEN CORP·Filed 2003·Granted Jul 11, 2006·48 cites·59 claims
- 0693US6448261B1Arylamino fused pyridinesBRISTOL MYERS SQUIBB PHARMA CO·Filed 2000·Granted Sep 10, 2002·55 cites·9 claims
- 0790US6569861B2Melanin concentrating hormone receptor ligandsNEUROGEN CORP·Filed 2001·Granted May 27, 2003·33 cites·27 claims
- 0889US6589952B2Imidazo[1,2-a]pyrazines for the treatment of neurological disordersBRISTOL MYERS SQUIBB PHARMA CO·Filed 2001·Granted Jul 8, 2003·30 cites·22 claims
- 0988US8003656B22-phenoxy pyrimidinone analoguesNEUROGEN CORP·Filed 2007·Granted Aug 23, 2011·10 cites·10 claims
- 1088US7304059B2Substituted quinazolin-4-ylamine analoguesNEUROGEN CORP·Filed 2006·Granted Dec 4, 2007·10 cites·58 claims
- 1186US6642230B2Imidazopyrimidines and imidazopyridines for the treatment of neurological disordersBRISTOL MYERS SQUIBB PHARMA CO·Filed 2001·Granted Nov 4, 2003·22 cites·5 claims
- 1286US6525056B2Heterocyclyl-substituted ring-fused pyridines and pyrimidines as corticotropin releasing hormone (CRH) antagonists, useful for treating cns and stress-related disordersBRISTOL MYERS SQUIBB CO·Filed 2001·Granted Feb 25, 2003·22 cites·16 claims
- 1384US7488740B2Substituted quinolin-4-ylamine analoguesNEUROGEN CORP·Filed 2004·Granted Feb 10, 2009·17 cites·48 claims
- 1484US6630476B2Pyrrolo [3,4-d] pyrimidines as corticotropin releasing factor (CRF) antagonistsBRISTOL MYERS SQUIBB PHARMA CO·Filed 2001·Granted Oct 7, 2003·13 cites·8 claims
- 1582US7935702B2Substituted biaryl quinolin-4-ylamine analoguesNEUROGEN CORP·Filed 2005·Granted May 3, 2011·6 cites·10 claims
- 1682US6734185B2Pyrrolo[3,4-d]pyrimidines as corticotropin releasing factor (CRF) antagonistsBRISTOL MYERS SQUIBB PHARMA CO·Filed 2003·Granted May 11, 2004·10 cites·6 claims
- 1781US7432275B2Carboxylic acid, phosphate or phosphonate substituted quinazolin-4-ylamine analogues as capsaicin receptor modulatorsNEUROGEN CORP·Filed 2003·Granted Oct 7, 2008·18 cites·22 claims
- 1881US6143743AImidazopyrimidines and imidazopyridines for the treatment of neurological disordersDU PONT PHARM CO·Filed 1998·Granted Nov 7, 2000·41 cites·8 claims
- 1979US6518271B11H-imidazo[4,5-d]pyridazin-7-one, and corresponding thiones as corticotropin releasing factor (CRF) receptor ligandsBRISTOL MYERS SQUIBB CO·Filed 2000·Granted Feb 11, 2003·11 cites·13 claims
- 2078US7566712B2Biaryl piperazinyl-pyridine analoguesNEUROGEN CORP·Filed 2004·Granted Jul 28, 2009·11 cites·59 claims
- 2177US6753336B2Melanin concentrating hormone receptor ligandsNEUROGEN CORP·Filed 2003·Granted Jun 22, 2004·7 cites·30 claims
- 2276US6107300AArylamino fused pyrimidinesDU PONT PHARM CO·Filed 1997·Granted Aug 22, 2000·35 cites·9 claims
- 2374US6124300AAryloxy- and arylthio- fused pyridines and pyrimidines and derivativesDU PONT PHARM CO·Filed 1997·Granted Sep 26, 2000·32 cites·15 claims
- 2473US9974775B2Substituted imidazoles as N-type calcium channel blockersJANSSEN PHARMACEUTICA NV·Filed 2016·Granted May 22, 2018·1 cites·16 claims
- 2573US6593337B1Tricyclic compounds useful as HIV reverse transcriptase inhibitorsBRISTOL MYERS SQUIBB PHARMA CO·Filed 2000·Granted Jul 15, 2003·3 cites·53 claims
- 2672US7329664B2Substituted (7-pyridyl-4-phenylamino-quinazolin-2-yl)-methanol analoguesNEUROGEN CORP·Filed 2004·Granted Feb 12, 2008·5 cites·39 claims
- 2770US6245769B1Heterocyclyl-substituted ring-fused pyridines and pyrimidines as corticotropin releasing hormone(CRH) antagonists, useful for treating CNS and stress-related disordersDU PONT PHARM CO·Filed 1998·Granted Jun 12, 2001·25 cites·15 claims
- 2869US7045529B2Imidazopyrimidinyl and imidazopyri dinyl derivativesBRISTOL MYERS SQUIBB PHARMA CO·Filed 2000·Granted May 16, 2006·4 cites·21 claims
- 2966US6906075B2Melanin concentrating hormone receptor ligands: substituted benzoimidazole analoguesNEUROGEN CORP·Filed 2003·Granted Jun 14, 2005·3 cites·16 claims
- 3065US10653673B2Substituted imidazoles as N-type calcium channel blockersJANSSEN PHARMACEUTICA NV·Filed 2018·Granted May 19, 2020·0 cites·16 claims
- 3164US6271380B11H-imidazo[4,5-d]pyridazin-7-ones, 3H-imidazo-[4,5-c]pyridin-4-ones and corresponding thiones as corticotropin releasing factor (CRF) receptor ligandsDU PONT PHARM CO·Filed 1999·Granted Aug 7, 2001·18 cites·12 claims
- 3261US9133204B25-membered heterocyclic amides and related compoundsLUNDBECK & CO AS H·Filed 2014·Granted Sep 15, 2015·0 cites·13 claims
- 3361US6362180B1Imidazopyridines for the treatment of neurological disordersBRISTOL MYERS SQUIBB PHARMA CO·Filed 1998·Granted Mar 26, 2002·14 cites·2 claims
- 3460US2008015183A1Substituted quinazolin-4-ylamine analoguesNEUROGEN CORP·Filed 2007·Application pending·0 cites
- 3559US9969687B2Compounds useful as CCR9 modulatorsNORGINE BV·Filed 2014·Granted May 15, 2018·1 cites·23 claims
- 3659US2009286767A1Substituted quinolin-4-ylamine analoguesNEUROGEN CORP·Filed 2009·Application pending·0 cites
- 3757US2010292236A15-Membered Heterocyclic Amides And Related CompoundsLUNDBECK & CO AS H·Filed 2008·Application pending·0 cites
- 3856US7323478B2Melanin concentrating hormone receptor ligandsNEUROGEN CORP·Filed 2004·Granted Jan 29, 2008·0 cites·15 claims
- 3956US7241765B2Melanin concentrating hormone receptor ligands: substituted 1-benzyl-4-aryl piperazine analoguesNEUROGEN CORP·Filed 2006·Granted Jul 10, 2007·0 cites·44 claims
- 4056US2008153857A1Substituted (7-pyridyl-4-phenylamino-quinazolin-2-yl)-methanol analoguesNEUROGEN CORP·Filed 2007·Application pending·0 cites
- 4155US2004176443A1Capsaicin receptor ligandsNEUROGEN CORP·Filed 2004·Application pending·0 cites
- 4254US2009082362A1Use of capsaicin receptor antagonists to treat symptoms of tear gas exposureBAKTHAVATCHALAM RAJAGOPAL·Filed 2008·Application pending·0 cites
- 4352US2016222014A1Compounds for regulating fak and/or src pathwaysASANA BIOSCIENCES LLC·Filed 2014·Application pending·0 cites
- 4450US2012190680A1Heteroaryl Amide AnaloguesBAKTHAVATCHALAM RAJAGOPAL·Filed 2008·Application pending·0 cites
- 4550US2004002498A1Tricyclic compounds useful as HIV reverse transcriptase inhibitorsFiled 2003·Application pending·0 cites
- 4650US2003220342A1Imidazo[1, 2-a] pyrazines for the treatment of irritable bowel syndromeFiled 2003·Application pending·0 cites
- 4748US2007105865A1Substituted bicyclic quinazolin-4-ylamine derivativesNEUROGEN CORP·Filed 2004·Application pending·0 cites
- 4848US2006040964A1Spiro[isobenzofuran-1,4'-piperidin]-3-ones and 3H-spiroisobenzofuran-1,4'-piperidinesBAKTHAVATCHALAM RAJAGOPAL·Filed 2005·Application pending·0 cites
- 4946US2007043049A1Substituted heterocyclic diarylamine analoguesNEUROGEN CORP·Filed 2004·Application pending·0 cites
- 5043US2006100245A1Substituted biphenyl-4-carboxylic acid arylamide analoguesNEUROGEN CORP·Filed 2003·Application pending·0 cites
Showing the top 50 of 58 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Rajagopal Bakthavatchalam files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →